Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actimmune in HCV-related Liver Fibrosis
NCT00043303Phase 2Completed
- Sponsor
- InterMune
- Start
- Sep 2001
- Modality
- Cytokines & Interferons
01
Overview
Phase 2, randomised, double-blind trial of interferon gamma-1b in Liver Fibrosis (LF) and Cirrhosis (3 arms), sponsored by InterMune. Primary endpoint: Ishak fibrosis score at 52 weeks. Started Sep 2001; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Liver Fibrosis (LF)Cirrhosis
Beyond the preview
Go deeper on NCT00043303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043303.